InvestWiserReal Heart
HEART · Nasdaq Stockholm · Healthcare
18.20SEK
0.0%last day
Price as of 2 October 2026
Performance
1 month
+0.6%
1 year
−10.8%
3 years, per year
−28.3%
5 years, per year
−40.4%
Largest fall, 3 years
−96.1%
Below the peak now
−98.9%
Volatility, 1 year
68.3%
Return with dividends reinvested.
Key figures
P/E
negative earnings
P/B
1.7
Dividend yield
0.0%
Return on equity
−29.8%
Net margin
–
Market value
15 m USD
Quality, value and trend
Where Real Heart stands against every Nordic stock today. 100 is best.
90
Profitability and a sound balance sheet over time. Better than 90% of Nordic stocks.
17
The price measured against earnings, assets and cash flow. Better than 17% of Nordic stocks.
49
The price development over the past year. Better than 49% of Nordic stocks.
49
Quality, value and trend together. Better than 49% of Nordic stocks.
About Real Heart
Real Heart is a company in healthcare, listed on Nasdaq Stockholm. The share trades in SEK. It has around 18 employees.
Scandinavian Real Heart AB (Publ) engages in the design and development of an artificial heart. The company develops Realheart TAH to treat advanced stage heart failure. It also develops RealVAD for pulsating left ventricle assist; PulsePump, a pulsating flow for heart and lung machines; and Sternal Prosthesis for fixing the sternum after open-chest surgery. The company was founded in 1999 and is based in Västerås, Sweden.
See the full analysis in InvestWiser.
The accounts, dividends, 40 years of charts and the comparison with other stocks are in the app.
See the full analysis